Preferred Treatment of Type 1.5 Diabetes

NCT00194896 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: rosiglitazone
DRUG: glyburide

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]